The Experts below are selected from a list of 348 Experts worldwide ranked by ideXlab platform

Ching-hsiang Shih - One of the best experts on this subject based on the ideXlab platform.

Man-ling Chang - One of the best experts on this subject based on the ideXlab platform.

Herschel W. Lawson - One of the best experts on this subject based on the ideXlab platform.

  • Report from the CDC. Pap Test Intervals Used by Physicians Serving Low-Income Women through the National Breast and Cervical Cancer Early Detection Program
    Journal of Womens Health, 2005
    Co-Authors: Crystale Purvis Cooper, Mona Saraiya, Teresa Abend Mclean, Judy Hannan, Jaime M. Liesmann, Shyanika W. Rose, Herschel W. Lawson
    Abstract:

    The National Breast and Cervical Cancer Early Detection Program (NBCCEDP), administered by the Centers for Disease Control and Prevention (CDC), provides breast and cervical cancer screening to low-income women who are uninsured or underinsured. For women with three consecutive annual Pap tests with normal findings, the NBCCEDP supports extending the screening interval to every 3 years. Thirteen telephone focus groups were conducted with physician providers in 17 states and the District of Columbia to investigate familiarity with NBCCEDP's triennial Pap test policy, the Pap test intervals actually used, and the factors influencing screening interval selection. No participants were familiar with NBCCEDP's triennial Pap test policy, and none reported routinely extending the screening interval after three consecutive annual Pap tests with normal findings. Two patterns of screening interval use were reported: annual screeners continued performing yearly Pap tests, and selective extended screeners offered an e...

  • cervical cancer screening among low income women results of a national screening Program 1991 1995
    Obstetrics & Gynecology, 1998
    Co-Authors: Herschel W. Lawson, Nancy C Lee, Sandra F Thames, Rosemarie Henson, Daniel S Miller
    Abstract:

    Abstract Objective: To evaluate the results of cervical cytology screening in the National Breast and Cervical Cancer Early Detection Program and to compare the findings with results from other screening Programs. Methods: We analyzed data on 312,858 women aged 18 years and older who received one or more Papanicolaou smears, and follow-up if indicated, from October 1991 through June 1995 at screening sites across the United States providing comprehensive National Breast and Cervical Cancer Early Detection Program services. Results: Of the women screened, more than half were 40 years or older; slightly less than half (44%) were of racial and ethnic minorities. During the first screening cycle, 3.8% of Papanicolaou tests were reported as abnormal (squamous intraepithelial lesion [SIL] or squamous cell cancer); proportions of abnormals decreased with increasing age. The age-adjusted rate of biopsy-confirmed cervical intraepithelial neoplasia (CIN) II or worse among women screened was 7.4 per 1000 Papanicolaou tests; rates of CIN were highest among young women, but cancer rates peaked among women in their 50s and 60s. The percentages of first screening cycle–Papanicolaou tests interpreted as high-grade SIL and squamous cell carcinoma associated with biopsy-confirmed CIN II or worse (the positive predictive value) were 56.0% for CIN II/III and 3.7% for invasive cancer. Of the 150 invasive cancers diagnosed, 54.0% were classified as local disease. Conclusion: Observed results emphasize the duality of cervical neoplasia—CIN in younger women and invasive cancer in older women. This finding points to the importance of reaching both younger and older women for cervical cancer screening. (Obstet Gynecol 1998;92:745–52.)

Vicki B. Benard - One of the best experts on this subject based on the ideXlab platform.

  • impact of the national breast and cervical cancer early Detection Program on cervical cancer mortality among uninsured low income women in the u s 1991 2007
    American Journal of Preventive Medicine, 2014
    Co-Authors: Donatus U. Ekwueme, Mona Saraiya, Jacqueline W. Miller, Ingrid J. Hall, Vicki B. Benard, Thomas J. Hoerger, Janet Royalty, Vladislav Uzunangelov, Evan R Myers
    Abstract:

    Background The benefits of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) on cervical cancer screening for participating uninsured low-income women have never been measured. Purpose To estimate the benefits in life-years (LYs) gained; quality-adjusted life-years (QALYs) gained; and deaths averted. Methods A cervical cancer simulation model was constructed based on an existing cohort model. The model was applied to NBCCEDP participants aged 18–64 years. Screening habits for uninsured low-income women were estimated using National Health Interview Survey data from 1990 to 2005 and NBCCEDP data from 1991 to 2007. The study was conducted during 2011–2012 and covered all 68 NBCCEDP grantees in 50 states, the District of Columbia, five U.S. territories, and 12 tribal organizations. Separate simulations were performed for the following three scenarios: (1) women who received NBCCEDP (Program) screening; (2) women who received screening without the Program (No Program); and (3) women who received no screening (No Screening). Results Among 1.8 million women screened in 1991–2007, the Program added 10,369 LYs gained compared to No Program, and 101,509 LYs gained compared to No Screening. The Program prevented 325 women from dying of cervical cancer relative to No Program, and 3,829 relative to No Screening. During this time period, the Program accounted for 15,589 QALYs gained when compared with No Program, and 121,529 QALYs gained when compared with No Screening. Conclusions These estimates suggest that NBCCEDP cervical cancer screening has reduced mortality among medically underserved low-income women who participated in the Program.

  • timeliness of breast cancer diagnosis and initiation of treatment in the national breast and cervical cancer early Detection Program 1996 2005
    American Journal of Public Health, 2010
    Co-Authors: Lisa C. Richardson, William Helsel, Janet Royalty, William Howe, William Kammerer, Vicki B. Benard
    Abstract:

    Objectives. To determine the effects of Program policy changes, we examined service delivery benchmarks for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).Methods. We analyzed NBCCEDP data for women with abnormal mammogram or clinical breast examination (n = 382 416) from which 23 701 cancers were diagnosed. We examined time to diagnosis and treatment for 2 time periods: 1996 to 2000 and 2001 to 2005. We compared median time for diagnostic, treatment initiation, and total intervals with the Kruskal–Wallis test. We calculated adjusted proportions (predicted marginals) with logistic regression to examine diagnosis and treatment within Program benchmarks (≤ 60 days) and time from screening to treatment (≤ 120 days).Results. Median diagnostic intervals decreased by 2 days (25 vs 23; P < .001). Median treatment initiation intervals increased by 2 days (12 vs 14; P < .001). Total intervals decreased by 3 days (43 vs 40; P < .001). Women meeting the 60-day be...

  • preventing cervical cancer overviews of the national breast and cervical cancer early Detection Program and 2 us immunization Programs
    Cancer, 2008
    Co-Authors: Kris Khan, Vicki B. Benard, Katherine B. Roland, Donatus U. Ekwueme, Robinette C Curtis, Shannon Stokley, Chastity Walker, Mona Saraiya
    Abstract:

    Three federal Programs with the potential to reduce cervical cancer incidence, morbidity, and mortality, especially among underserved populations, are administered by the Centers for Disease Control and Prevention (CDC): the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), the Vaccines for Children (VFC) Program, and the Section 317 immunization grant Program. The NBCCEDP provides breast and cervical cancer screening and diagnostic services to uninsured and underinsured women. The VFC Program and the Section 317 immunization grant Program provide vaccines, including human papillomavirus (HPV) vaccine, to targeted populations at no cost for these vaccines. This article describes the Programs, their histories, populations served, services offered, and roles in preventing cervical cancer through HPV vaccination and cervical cancer screening. Potential long-term reduction in healthcare costs resulting from HPV vaccination is also discussed. As an example of an initiative to vaccinate uninsured women aged 19-26 years through a cancer services Program, a state-based effort that was recently launched in New York, is highlighted.

Lisa C. Richardson - One of the best experts on this subject based on the ideXlab platform.

  • timeliness of breast cancer diagnosis and initiation of treatment in the national breast and cervical cancer early Detection Program 1996 2005
    American Journal of Public Health, 2010
    Co-Authors: Lisa C. Richardson, William Helsel, Janet Royalty, William Howe, William Kammerer, Vicki B. Benard
    Abstract:

    Objectives. To determine the effects of Program policy changes, we examined service delivery benchmarks for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).Methods. We analyzed NBCCEDP data for women with abnormal mammogram or clinical breast examination (n = 382 416) from which 23 701 cancers were diagnosed. We examined time to diagnosis and treatment for 2 time periods: 1996 to 2000 and 2001 to 2005. We compared median time for diagnostic, treatment initiation, and total intervals with the Kruskal–Wallis test. We calculated adjusted proportions (predicted marginals) with logistic regression to examine diagnosis and treatment within Program benchmarks (≤ 60 days) and time from screening to treatment (≤ 120 days).Results. Median diagnostic intervals decreased by 2 days (25 vs 23; P < .001). Median treatment initiation intervals increased by 2 days (12 vs 14; P < .001). Total intervals decreased by 3 days (43 vs 40; P < .001). Women meeting the 60-day be...

  • time to diagnosis and treatment of breast cancer results from the national breast and cervical cancer early Detection Program 1991 1995
    American Journal of Public Health, 2000
    Co-Authors: L S Caplan, D S May, Lisa C. Richardson
    Abstract:

    Objectives. This study examined times to diagnosis and treatment for medically underserved women screened for breast cancer. Methods. Intervals from first positive screening test to diagnosis to initiation of treatment were determined for 1659 women 40 years and older diagnosed with breast cancer. Results. Women with abnormal mammograms had shorter diagnostic intervals than women with abnormal clinical breast examinations and normal mammograms. Women with selfreported breast symptoms had shorter diagnostic intervals than asymptomatic women. Diagnostic intervals were less than 60 days in 78% of cases. Treatment intervals were generally 2 weeks or less. Conclusions. Most women diagnosed with breast cancer were followed up in a timely manner after screening. Further investigation is needed to identify and then address factors associated with longer diagnostic and treatment intervals to maximize the benefits of early Detection. (Am J Public Health. 2000;90:130‐134)